Biohaven Pharmaceutical
BHVN
#3534
Rank
A$4.70 B
Marketcap
$46.08
Share price
3.30%
Change (1 day)
-48.88%
Change (1 year)

Biohaven Pharmaceutical (BHVN) - Cash on Hand

Cash on Hand as of December 2024 : A$0.76 Billion

According to Biohaven Pharmaceutical 's latest financial reports the company has A$0.76 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Biohaven Pharmaceutical - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.78 B39.42%
2023-12-31A$0.56 B-18.04%
2022-12-31A$0.68 B551.82%
2021-12-31A$0.10 B-2.23%
2020-12-31A$0.10 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.40 B-47.33%๐Ÿ‡บ๐Ÿ‡ธ USA